RE: check the current level 2Well, keep in mind that this company is highly dependent on the next quarter financial release when the approved drug is launched (which includes the sales from that drug)
Only then will the stock rise, right now it's just going through the waiting process.
Remember the large spike in volume after MIP entered the bio venture conference in montreal of 6 million shares; if large institutions and health science companies find an interest in this stock instantaneously the day after the conference, then yeah there is some substance to MIP.
It's just the waiting process, it can be frustrating, but the next quarter should be very interesting.. Keep your eyes open okay?